kisspeptin-54



kisspeptin-54

G1GG1T2TT2S3SS3L4LL4S5SS5P6PP6P7PP7P8PP8E9EE9S10SS10S11SS11G12GG12S13SS13P14PP14Q15QQ15Q16QQ16P17PP17G18GG18L19LL19S20SS20A21AA21P22PP22H23HH23S24SS24R25RR25Q26QQ26I27II27P28PP28A29AA29P30PP30Q31QQ31G32GG32A33AA33V34VV34L35LL35V36VV36Q37QQ37R38RR38E39EE39K40KK40D41DD41L42LL42P43PP43N44NN44Y45YY45N46NN46W47WW47... and 7 more residue(s)...... and 7 more residue(s)

SMILES None
InChIKey None
Sequence GTSLSPPPESSGSPQQPGLSAPHSRQIPAPQGAVLVQREKDLPNYNWNSFGLRF

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

kisspeptin-54

G1GG1T2TT2S3SS3L4LL4S5SS5P6PP6P7PP7P8PP8E9EE9S10SS10S11SS11G12GG12S13SS13P14PP14Q15QQ15Q16QQ16P17PP17G18GG18L19LL19S20SS20A21AA21P22PP22H23HH23S24SS24R25RR25Q26QQ26I27II27P28PP28A29AA29P30PP30Q31QQ31G32GG32A33AA33V34VV34L35LL35V36VV36Q37QQ37R38RR38E39EE39K40KK40D41DD41L42LL42P43PP43N44NN44Y45YY45N46NN46W47WW47... and 7 more residue(s)...... and 7 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.